These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11453573)

  • 21. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 22. [Botulinum toxin for neurogenic dysphagia after brainstem ischemia : Single injection as a treatment of an esophageal opening disorder].
    Schradt F; Stösser S; Hänle M; Kassubek J; Lindner-Pfleghar B; Neugebauer H
    Nervenarzt; 2019 Feb; 90(2):191-193. PubMed ID: 30171305
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of vulvodynia with botulinum toxin A.
    Tieu KD; MacGregor JL
    Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
    [No Abstract]   [Full Text] [Related]  

  • 24. Arginiemia is not a contraindication for botulinum toxin injection.
    Kelle B; Yavuz F
    J Pediatr Orthop B; 2016 Jan; 25(1):86-7. PubMed ID: 26583787
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
    Baumann LS; Halem ML
    Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
    [No Abstract]   [Full Text] [Related]  

  • 26. [Communication and language problems in children with nemaline myopathy].
    Cervera-Merida JF; Villa-Garcia I; Ygual-Fernandez A
    Rev Neurol; 2017 Feb; 64(s01):S89-S94. PubMed ID: 28256693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation.
    Masiero S; Briani C; Marchese-Ragona R; Giacometti P; Costantini M; Zaninotto G
    J Rehabil Med; 2006 May; 38(3):201-3. PubMed ID: 16702088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders].
    García Ron A; Miranda MC; Garriga Braun C; Jensen Verón J; Torrens Martinez J; Diez Hanbino MP
    An Pediatr (Barc); 2012 Oct; 77(4):289-91. PubMed ID: 22652186
    [No Abstract]   [Full Text] [Related]  

  • 29. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
    Dressler D
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with botulinum toxin in children with chronic anal fissure.
    Husberg B; Malmborg P; Strigård K
    Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
    Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
    Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin for urogenital conditions.
    Eccleston KJ; Woolley PD
    Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating childhood hyperhidrosis with botulinum toxin type A.
    Bhakta BB; Roussounnis SH
    Arch Dis Child; 2002 Jan; 86(1):68. PubMed ID: 11806899
    [No Abstract]   [Full Text] [Related]  

  • 35. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter.
    Murry T; Wasserman T; Carrau RL; Castillo B
    Am J Otolaryngol; 2005; 26(3):157-62. PubMed ID: 15858769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of Frey's syndrome with botulinum toxin].
    Acher-Chenebaux A; Maillard H; Potier A; Lejoyeux P; Célérier P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):703-5. PubMed ID: 16230925
    [No Abstract]   [Full Text] [Related]  

  • 37. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease.
    Triadafilopoulos G; Gandhy R; Barlow C
    Parkinsonism Relat Disord; 2017 Nov; 44():33-37. PubMed ID: 28847681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
    Deshpande AV; Sampang R; Smith GH
    ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of globus by upper esophageal sphincter injection with botulinum A toxin.
    Halum SL; Butler SG; Koufman JA; Postma GN
    Ear Nose Throat J; 2005 Feb; 84(2):74. PubMed ID: 15794538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.